Tronox Reports First Quarter 2025 Financial Results
STAMFORD, Conn.,
First Quarter 2025 Financial Highlights:
- Revenue of
$738 million , a 9% increase compared to the prior quarter and a 5% decrease compared to the prior year - Loss from operations of
$61 million ; Net loss of$111 million including$87 million of restructuring and other charges, primarily non-cash costs associated with the idling of the Company's Botlek pigment plant as announced in March; adjusted net loss was$24 million (non-GAAP) - GAAP diluted loss per share was
$0.70 ; Adjusted diluted loss per share was$0.15 (non-GAAP) - Adjusted EBITDA of
$112 million ; Adjusted EBITDA margin of 15.2% (non-GAAP) - Capital expenditures of
$110 million in the quarter
Outlook:
- Maintaining previous guidance for 2025 Revenue (
$3.0-3.4 billion ), Adjusted EBITDA ($525-625 million ), and free cash flow (greater than$50 million ) - Capital expenditures reduced to be less than
$365 million in 2025 - Actions underway expected to deliver
$125-$175 million in sustainable, run-rate cost improvements by end of 2026
This outlook is based on
------ |
Note: For the Company's guidance with respect to 2025 Adjusted EBITDA and free cash flow, we are not able to provide without unreasonable effort the most directly comparable GAAP financial measure, or reconciliation to such GAAP financial measure, because certain items that impact such measures are uncertain, out of the Company's control or cannot be reasonably predicted. |
Summary of Select Financial Results for the Quarter Ending
($M unless otherwise noted) |
|
Q1 2025 |
Q1 2024 |
Y-o-Y % ∆ |
Q4 2024 |
Q-o-Q % ∆ |
Revenue |
|
|
|
(5) % |
|
9 % |
TiO2 |
|
|
|
(3) % |
|
10 % |
Zircon |
|
|
|
(22) % |
|
(8) % |
Other products |
|
|
5 % |
|
25 % |
|
(Loss) Income from operations |
|
( |
|
n/m |
|
n/m |
Net (Loss) Income attributable to |
( |
( |
n/m |
( |
n/m |
|
GAAP diluted (loss) earnings per share |
( |
( |
n/m |
( |
n/m |
|
Adjusted diluted (loss) earnings per share |
( |
( |
n/m |
|
n/m |
|
Adjusted EBITDA |
|
|
|
(15) % |
|
(13) % |
Adjusted EBITDA Margin % |
|
15.2 % |
16.9 % |
(170) bps |
19.1 % |
(390) bps |
Free cash flow |
|
( |
( |
n/m |
( |
n/m |
|
|
|
|
|
|
|
|
Y-o-Y % ∆ |
Q-o-Q % ∆ |
||||
|
Volume |
Price / Mix |
FX |
Volume |
Price / Mix |
FX |
TiO2 |
(1) % |
(1) % |
(1) % |
12 % |
(2) % |
0 % |
Zircon |
(15) % |
(7) % |
— |
(6) % |
(2) % |
— |
CEO's Remarks
Chief Executive Officer
"In response to ongoing macroeconomic volatility,
First Quarter 2025 Results
(Comparisons are to prior year (Q1 2025 vs. Q1 2024) unless otherwise noted)
The Company recorded first quarter revenue of
Revenue from TiO2 sales was
Zircon revenue decreased 22% to
Revenue from other products was
Net loss attributable to
Adjusted EBITDA of
Sequentially, Adjusted EBITDA decreased 13% due to higher production costs, lower average selling prices including mix and higher corporate costs, partially offset by higher sales volumes and favorable exchange rate movements.
The Company's selling, general and administrative expenses were
Balance Sheet, Cash Flow and Capital Allocation
Free cash flow for the quarter was a use of
Outlook
Webcast Conference Call
Replay: A webcast replay will be available at investor.tronox.com following the call.
About
Cautionary Statement about Forward-Looking Statements
Statements in this release that are not historical are forward-looking statements within the meaning of the
Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for our management to predict all risks and uncertainties, nor can management assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Although we believe the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance, synergies or achievements. Neither we nor any other person assumes responsibility for the accuracy or completeness of any of these forward-looking statements. You should not rely upon forward-looking statements as predictions of future events. Unless otherwise required by applicable laws, we undertake no obligation to update or revise any forward-looking statements, whether because of new information or future developments.
Use of Non-GAAP Information
To provide investors and others with additional information regarding the financial results of
Investor Relations and Media Contact:
+1.203.705.3701 extension: 103701 (Media)
+1.646.960.6598 (Investor Relations)
|
|||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS ( |
|||
(UNAUDITED) |
|||
(Millions of |
|||
|
|
|
|
|
|
|
|
|
Three Months Ended |
||
|
2025 |
|
2024 |
Net sales |
$ 738 |
|
$ 774 |
Cost of goods sold |
639 |
|
654 |
Gross profit |
99 |
|
120 |
Restructuring and other charges |
86 |
|
— |
Selling, general and administrative expenses |
74 |
|
79 |
(Loss) Income from operations |
(61) |
|
41 |
Interest expense |
(42) |
|
(42) |
Interest income |
2 |
|
4 |
Other expense, net |
(5) |
|
(1) |
(Loss) Income before income taxes |
(106) |
|
2 |
Income tax provision |
(5) |
|
(11) |
Net loss |
(111) |
|
(9) |
Net (loss) income attributable to noncontrolling interest |
— |
|
— |
Net loss attributable to |
$ (111) |
|
$ (9) |
|
|
|
|
|
|
|
|
Loss per share: |
|
|
|
Basic |
$ (0.70) |
|
$ (0.06) |
Diluted |
$ (0.70) |
|
$ (0.06) |
|
|
|
|
Weighted average shares outstanding, basic (in thousands) |
158,138 |
|
157,331 |
Weighted average shares outstanding, diluted (in thousands) |
158,138 |
|
157,331 |
|
|
|
|
Other Operating Data: |
|
|
|
Capital expenditures |
110 |
|
76 |
Depreciation, depletion and amortization expense |
71 |
|
72 |
|
|||
RECONCILIATION OF NON- |
|||
(UNAUDITED) |
|||
(Millions of |
|||
|
|
|
|
RECONCILIATION OF NET LOSS ATTRIBUTABLE TO TRONOX HOLDINGS PLC ( |
|||
TO ADJUSTED NET LOSS ATTRIBUTABLE TO TRONOX HOLDINGS PLC (NON- |
|||
|
|||
|
|
|
|
|
|
|
|
|
Three Months Ended |
||
|
2025 |
|
2024 |
|
|
|
|
Net loss attributable to |
$ (111) |
|
$ (9) |
|
|
|
|
Restructuring and other charges (a) |
86 |
|
— |
Other (b) |
1 |
|
2 |
Adjusted net loss attributable to |
$ (24) |
|
$ (7) |
|
|
|
|
Diluted net loss per share ( |
$ (0.70) |
|
$ (0.06) |
|
|
|
|
Restructuring and other charges, per share |
0.54 |
|
— |
Other, per share |
0.01 |
|
0.01 |
Diluted adjusted net loss per share attributable to |
$ (0.15) |
|
$ (0.05) |
|
|
|
|
Weighted average shares outstanding, diluted (in thousands) |
158,138 |
|
157,331 |
|
|
|
|
(1) Diluted adjusted net income per share attributable to |
|||
(a) Represents restructuring and other charges associated with the Botlek plant idling. |
|||
(b) Represents other activity not representative of the ongoing operations of the Company. |
|
|||
CONDENSED CONSOLIDATED BALANCE SHEETS |
|||
(UNAUDITED) |
|||
(Millions of |
|||
|
|
|
|
|
|
|
|
|
|
|
|
ASSETS |
|
|
|
Current Assets |
|
|
|
Cash and cash equivalents |
$ 138 |
|
$ 151 |
Restricted cash |
— |
|
1 |
Accounts receivable (net of allowance for credit losses of |
319 |
|
266 |
Inventories, net |
1,605 |
|
1,551 |
Prepaid and other assets |
129 |
|
184 |
Income taxes receivable |
2 |
|
2 |
Total current assets |
2,193 |
|
2,155 |
|
|
|
|
Noncurrent Assets |
|
|
|
Property, plant and equipment, net |
1,922 |
|
1,927 |
Mineral leaseholds, net |
614 |
|
616 |
Intangible assets, net |
243 |
|
244 |
Lease right of use assets, net |
137 |
|
140 |
Deferred tax assets |
831 |
|
830 |
Other long-term assets |
129 |
|
126 |
Total assets |
$ 6,069 |
|
$ 6,038 |
|
|
|
|
LIABILITIES AND EQUITY |
|
|
|
Current Liabilities |
|
|
|
Accounts payable |
$ 478 |
|
$ 499 |
Accrued liabilities |
239 |
|
247 |
Short-term lease liabilities |
23 |
|
24 |
Short-term debt |
183 |
|
65 |
Long-term debt due within one year |
38 |
|
35 |
Income taxes payable |
— |
|
4 |
Total current liabilities |
961 |
|
874 |
|
|
|
|
Noncurrent Liabilities |
|
|
|
Long-term debt, net |
2,753 |
|
2,759 |
Pension and postretirement healthcare benefits |
86 |
|
85 |
Asset retirement obligations |
191 |
|
172 |
Environmental liabilities |
41 |
|
40 |
Long-term lease liabilities |
106 |
|
107 |
Deferred tax liabilities |
181 |
|
174 |
Other long-term liabilities |
44 |
|
36 |
Total liabilities |
4,363 |
|
4,247 |
|
|
|
|
Commitments and Contingencies |
|
|
|
Shareholders' Equity |
|
|
|
|
2 |
|
2 |
Capital in excess of par value |
2,089 |
|
2,084 |
Retained earnings |
425 |
|
555 |
Accumulated other comprehensive loss |
(842) |
|
(880) |
|
1,674 |
|
1,761 |
Noncontrolling interest |
32 |
|
30 |
Total equity |
1,706 |
|
1,791 |
Total liabilities and equity |
$ 6,069 |
|
$ 6,038 |
|
|||
CONSOLIDATED STATEMENTS OF CASH FLOWS |
|||
(UNAUDITED) |
|||
(Millions of |
|||
|
|
|
|
|
|
|
|
|
Three Months Ended |
||
|
2025 |
|
2024 |
Cash Flows from Operating Activities: |
|
|
|
Net loss |
$ (111) |
|
$ (9) |
Adjustments to reconcile net loss to net cash provided by operating activities: |
|
|
|
Depreciation, depletion and amortization |
71 |
|
72 |
Deferred income taxes |
4 |
|
11 |
Share-based compensation expense |
5 |
|
6 |
Amortization of deferred debt issuance costs and discount on debt |
2 |
|
2 |
Restructuring and other charges |
86 |
|
- |
Other non-cash items affecting net income (loss) |
12 |
|
16 |
Changes in assets and liabilities: |
|
|
|
Increase in accounts receivable, net of allowance for credit losses |
(49) |
|
(94) |
(Increase) decrease in inventories, net |
(35) |
|
11 |
Decrease in prepaid and other assets |
18 |
|
16 |
Restructuring payments |
(2) |
|
- |
Decrease in accounts payable and accrued liabilities |
(22) |
|
(49) |
Net changes in income tax payables and receivables |
(4) |
|
(3) |
Changes in other non-current assets and liabilities |
(7) |
|
(8) |
Cash used in operating activities |
(32) |
|
(29) |
|
|
|
|
Cash Flows from Investing Activities: |
|
|
|
Capital expenditures |
(110) |
|
(76) |
Loans |
15 |
|
- |
Cash used in investing activities |
(95) |
|
(76) |
|
|
|
|
Cash Flows from Financing Activities: |
|
|
|
Repayments of short-term debt |
(6) |
|
(6) |
Repayments of long-term debt |
(6) |
|
(5) |
Proceeds from short-term debt |
121 |
|
- |
Dividends paid |
- |
|
(1) |
Restricted stock and performance-based shares settled in cash for |
(1) |
|
- |
Cash provided by (used in) financing activities |
108 |
|
(12) |
|
|
|
|
Effects of exchange rate changes on cash and cash equivalents and |
5 |
|
(2) |
|
|
|
|
Net decrease in cash and cash equivalents and restricted cash |
(14) |
|
(119) |
Cash and cash equivalents and restricted cash at beginning of period |
152 |
|
273 |
Cash and cash equivalents and restricted cash at end of period |
$ 138 |
|
$ 154 |
|
|||
RECONCILIATION OF NET LOSS TO EBITDA AND ADJUSTED EBITDA, ADJUSTED EBITDA AS A % OF NET SALES AND NET DEBT TO |
|||
(UNAUDITED) |
|||
(Millions of |
|||
|
|
|
|
|
|
|
|
|
Three Months Ended |
||
|
2025 |
|
2024 |
|
|
|
|
Net loss ( |
$ (111) |
|
$ (9) |
Interest expense |
42 |
|
42 |
Interest income |
(2) |
|
(4) |
Income tax provision |
5 |
|
11 |
Depreciation, depletion and amortization expense |
71 |
|
72 |
EBITDA (non- |
5 |
|
112 |
Share-based compensation (a) |
5 |
|
6 |
Accretion expense and other adjustments to asset retirement |
7 |
|
7 |
Accounts receivable securitization program (c) |
4 |
|
3 |
Foreign currency remeasurement (d) |
1 |
|
(2) |
Restructuring and other charges (e) |
86 |
|
— |
Other items (f) |
4 |
|
5 |
Adjusted EBITDA (non- |
$ 112 |
|
$ 131 |
|
|
|
|
|
Three Months Ended |
||
|
2025 |
|
2024 |
Net sales |
$ 738 |
|
$ 774 |
Net loss ( |
$ (111) |
|
$ (9) |
Net loss ( |
(15.0) % |
|
(1.2) % |
Adjusted EBITDA (non- |
15.2 % |
|
16.9 % |
|
|
|
|
|
|
|
|
Long-term debt, net |
$ 2,753 |
|
$ 2,759 |
Short-term debt |
183 |
|
65 |
Long-term debt due within one year |
38 |
|
35 |
(Less) Cash and cash equivalents |
(138) |
|
(151) |
Net debt |
$ 2,836 |
|
$ 2,708 |
Trailing-twelve month Adjusted EBITDA (non- |
$ 545 |
|
$ 564 |
Net debt to trailing-twelve month Adjusted EBITDA (non- |
5.2x |
|
4.8x |
|
|
|
|
|
|
|
|
(a) Represents non-cash share-based compensation. |
|||
(b) Primarily represents accretion expense and other noncash adjustments to asset retirement obligations and environmental liabilities. |
|||
(c) Primarily represents expenses associated with the Company's accounts receivable securitization program which is used as a source of liquidity in the |
|||
(d) Represents realized and unrealized gains and losses associated with foreign currency remeasurement related to third-party and intercompany |
|||
(e) Represents restructuring and other charges associated with the Botlek plant idling. |
|||
(f) Includes noncash pension and postretirement costs, asset write-offs and other items included in "Selling general and administrative expenses", "Cost |
|
|
FREE CASH FLOW (NON- |
|
(UNAUDITED) |
|
(Millions of |
|
|
|
|
|
|
|
|
|
The following table reconciles cash used in operating activities to free cash flow for the three months ended |
|
|
|
|
Three Months Ended |
Cash used in operating activities |
$ (32) |
Capital expenditures |
(110) |
Free cash flow (non- |
$ (142) |
|
|||||||
RECONCILIATION OF TRAILING TWELVE MONTH NET INCOME (LOSS) TO EBITDA AND ADJUSTED EBITDA (NON- |
|||||||
(UNAUDITED) |
|||||||
(Millions of |
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Trailing Twelve |
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) ( |
|
$ 10 |
$ (25) |
$ (30) |
$ (111) |
|
$ (156) |
Interest expense |
|
42 |
42 |
41 |
42 |
|
167 |
Interest income |
|
(2) |
(3) |
(1) |
(2) |
|
(8) |
Income tax provision |
|
45 |
26 |
45 |
5 |
|
121 |
Depreciation, depletion |
|
72 |
70 |
71 |
71 |
|
284 |
EBITDA (non- |
|
167 |
110 |
126 |
5 |
|
408 |
Share-based |
|
4 |
7 |
4 |
5 |
|
20 |
Foreign currency |
|
4 |
8 |
(11) |
1 |
|
2 |
Accretion expense and |
|
7 |
8 |
1 |
7 |
|
23 |
Accounts receivable |
|
4 |
4 |
4 |
4 |
|
16 |
Sale of royalty interest (e) |
|
(28) |
— |
— |
— |
|
(28) |
Restructuring and other |
|
— |
— |
— |
86 |
|
86 |
Loss on extinguishment |
|
— |
3 |
— |
— |
|
3 |
Other items (h) |
|
3 |
3 |
5 |
4 |
|
15 |
Adjusted EBITDA (non- |
|
$ 161 |
$ 143 |
$ 129 |
$ 112 |
|
$ 545 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) Represents non-cash share-based compensation. |
|||||||
(b) Represents realized and unrealized gains and losses associated with foreign currency remeasurement related to third-party and intercompany |
|||||||
(c) Primarily represents accretion expense and other noncash adjustments to asset retirement obligations and environmental liabilities. |
|||||||
(d) Primarily represents expenses associated with the Company's accounts receivable securitization program which is used as a source of liquidity in the |
|||||||
(e) Represents the sale of a royalty interest in certain Canadian mineral properties, net of associated transaction costs included in "Other expense, net" |
|||||||
(f) Represents restructuring and other charges associated with the Botlek plant idling. |
|||||||
(g) Represents the loss in connection with the refinancing of the Term Loan Facility in the US. |
|||||||
(h) Includes noncash pension and postretirement costs, asset write-offs, severance expense and other items included in "Selling general and |
View original content to download multimedia:https://www.prnewswire.com/news-releases/tronox-reports-first-quarter-2025-financial-results-302443249.html
SOURCE